Tags: Pfizer | Lawsuit | generic | drugs

Retailers Accuse Pfizer of Delaying Generic Drugs

Friday, 06 July 2012 03:15 PM EDT

Five large drug and grocery chains are suing Pfizer Inc. and a second drugmaker, alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.

Lipitor, the world's top-selling drug ever, got U.S. generic competition on Nov. 30.

A lawsuit filed by Walgreen Co., the Kroger Co. and three other retailers claims generics should have been available nearly two years earlier, when Lipitor's original patent expired.

The lawsuit accuses Pfizer of patent fraud as well as "illegal, anti-competitive conduct" with generic drugmaker Ranbaxy Laboratories to block other generic drugmakers from selling versions of Lipitor until recently. The suit also accuses Pfizer of making deals with prescription benefit managers to limit sales of generic Lipitor.

Pfizer denies the claims and says it will fight the lawsuit. Ranbaxy declined comment.

© Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


133
2012-15-06
Friday, 06 July 2012 03:15 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved